Literature DB >> 26995293

Prevalence of hypercalcemia related to hypervitaminosis D in clinical practice.

C Pérez-Barrios1, E Hernández-Álvarez2, I Blanco-Navarro2, B Pérez-Sacristán3, F Granado-Lorencio4.   

Abstract

BACKGROUND & AIMS: Recent interest in vitamin D has led to a substantial increase in the use of vitamin D supplements. Vitamin D intoxication may be a concern as hypervitaminosis D can result in irreversible calcification of soft tissues so that it is important to detect early markers of vitamin D intoxication. Our aim was to assess the simultaneous presence of biochemical markers of vitamin D toxicity (i.e. hypervitaminosis D, hypercalcemia) and determine the concentrations of 25-OH-vitamin D at which the risk of hypercalcemia, and thus toxicity, might begin.
METHODS: We evaluated retrospectively a 6-year period during which 25.567 samples were assessed for 25-OH-vitamin D status by UHPLC. Hypervitaminosis D was defined at serum 25-OH-vitamin D >160 nmol/L. Serum and urine calcium, phosphorus and iPTH were also recorded, if available. Medical history revision was performed in subjects displaying simultaneously hypervitaminosis D and hypercalcemia.
RESULTS: Overall, hypervitaminosis D was found in 475 samples (1.86%) of which 51 displayed hypercalcemia (11.1%). A total of 382 samples were identified as the first record of hypervitaminosis D and 39 presented hypercalcemia (10.2%), most of them at 25-OH-vitamin D levels between 161 and 375 nmol/L. Only in 15 subjects, hypercalcemia could be directly attributed to vitamin D and serum 25-OH-vitamin D ranged between 164 and 1139 nmol/l. In no case, serum calcium achieved concentrations considered as critical values (>13 mg/dl).
CONCLUSION: Hypercalcemia due to vitamin D represented <4% of the total hypervitaminosis D detected and <0.1% of the tests performed. However, a highly variable response was observed and most subjects presented hypercalcemia at serum concentrations of 25-OH-vitamin D < 375 nmol/L.
Copyright © 2016 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Clinical practice; Hipervitaminosis D; Hypercalcemia; Vitamin D status; Vitamin D toxicity

Mesh:

Substances:

Year:  2016        PMID: 26995293     DOI: 10.1016/j.clnu.2016.02.017

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  8 in total

Review 1.  A review of the growing risk of vitamin D toxicity from inappropriate practice.

Authors:  Peter N Taylor; J Stephen Davies
Journal:  Br J Clin Pharmacol       Date:  2018-04-16       Impact factor: 4.335

2.  Hypervitaminosis D and nephrocalcinosis: too much of a good thing?

Authors:  Mandy Wan; Jignesh Patel; Greta Rait; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2022-03-29       Impact factor: 3.651

3.  Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients.

Authors:  Roland N Dickerson; Stephen C Turner; Whitney L Holmes; Edward T Van Matre; Joseph M Swanson; Saskya Byerly; Dina M Filiberto; Peter E Fischer
Journal:  Nutrients       Date:  2022-04-15       Impact factor: 6.706

4.  Hypervitaminosis D without toxicity.

Authors:  Jasmin Rahesh; Victoria Chu; Alan N Peiris
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-10-08

5.  Evaluation of vitamin D3 intakes up to 15,000 international units/day and serum 25-hydroxyvitamin D concentrations up to 300 nmol/L on calcium metabolism in a community setting.

Authors:  S M Kimball; N Mirhosseini; M F Holick
Journal:  Dermatoendocrinol       Date:  2017-04-13

Review 6.  A Brief Review of the Effects of Vitamin D on Multiple Sclerosis.

Authors:  Andrei Miclea; Maud Bagnoud; Andrew Chan; Robert Hoepner
Journal:  Front Immunol       Date:  2020-05-06       Impact factor: 7.561

7.  100 YEARS OF VITAMIN D: Supraphysiological doses of vitamin D changes brainwave activity patterns in rats.

Authors:  Gabriella Oliveira Lima; Alex Luiz Menezes da Silva; Julianne Elba Cunha Azevedo; Chirlene Pinheiro Nascimento; Luana Rodrigues Vieira; Akira Otake Hamoy; Luan Oliveira Ferreira; Verônica Regina Lobato Oliveira Bahia; Nilton Akio Muto; Dielly Catrina Favacho Lopes; Moisés Hamoy
Journal:  Endocr Connect       Date:  2022-03-14       Impact factor: 3.335

Review 8.  Hypercalcemic Disorders in Children.

Authors:  Victoria J Stokes; Morten F Nielsen; Fadil M Hannan; Rajesh V Thakker
Journal:  J Bone Miner Res       Date:  2017-11-02       Impact factor: 6.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.